Back to search results

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

Abroad (travel likely)RecruitingPHASE2

Conditions

Duchenne Muscular Dystrophy · Exon 44 · DMD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Children's Hospital Colorado, Aurora, Colorado, United States

    Contact: Study coordinator (Hannah Kleiner) · hannah.kleiner@childrenscolorado.org

  • Rare Disease Research, LLC - FL, Kissimmee, Florida, United States

    Contact: Study coordinator (Marcial Almaraz) · marcial.almaraz@rarediseaseresearch.com

  • Rare Disease Research, Atlanta, Georgia, United States

    Contact: Study coordinator (Julia Zhu) · julia.zhu@rarediseaseresearch.com

  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Raven Hill) · rhill@luriechildrens.org
    Contact: Study coordinator (Alka Maheshwari) · amaheshwari@luriechildrens.org

  • University of Kansas Medical Center (KUMC), Kansas City, Kansas, United States

    Contact: Study coordinator (Rebecca Clay) · rclay@kumc.edu

  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Angela Edmondson) · Angela.Edmondson@cchmc.org

  • The Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Karen Monono) · mononok@email.chop.edu

  • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Vibha Chauhan) · vibha.chauhan@chp.edu

  • UT Southwestern/Children's Health, Dallas, Texas, United States

    Contact: Study coordinator (Deniece Winston) · Deniece.Winston@UTSouthwestern.edu

  • Virginia Commonwealth University Health System, Richmond, Virginia, United States

    Contact: Study coordinator (Andrea Jewell) · andrea.jewell@vcuhealth.org

  • Perth Children's Hospital, Nedlands, Western Australia, Australia

    Contact: Study coordinator (Jane Jones) · Jane.Jones2@health.wa.gov.au

  • Alberta Children's Hospital, Calgary, Alberta, Canada

    Contact: Study coordinator (Julie Dao) · julie.dao@ucalgary.ca

  • British Columbia Children's Hospital, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Gabe Massarotto) · gabe.massarotto@cw.bc.ca

  • London Health Sciences Centre, London, Ontario, Canada

    Contact: Study coordinator (Rhiannon Hicks) · rhiannon.hicks@lhsc.on.ca

  • Fukui Prefectural Hospital, Fukui-shi, Fukui, Japan

  • National Hospital Organization Nagara Medical Center, Nagara, Gifu-shi, Gifu, Japan

    Contact: Study coordinator (Clinical Trial Management Office) · yonekura.kei.wu@mail.hosp.go.jp

  • NHO Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan

    Contact: Study coordinator (Clinical Trial Office) · 410-chiken@mail.hosp.go.jp

  • Shiga General Hospital, Moriyama-shi, Shiga, Japan

    Contact: Study coordinator (Children's Building) · kenji.s.address@gmail.com

  • National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan

  • Starship Children's Hospital, Auckland, New Zealand

    Contact: Study coordinator (Margaret Joppa) · mjoppa@adhb.govt.nz

  • Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam, South Korea

    Contact: Study coordinator (JaeYoon Kim) · lusterwuzz@naver.com

  • Seoul National University Hospital, Seoul, South Korea

    Contact: Study coordinator (Hyeon Ju Kwon) · hjkwon@snuh.org; 49041@snuh.org

  • Ankara Bilkent City Hospital, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Gozde Akgun) · gozde.akgun@medex-smo.com

  • Yeditepe University Kosuyolu Hospital, Istanbul, Turkey (Türkiye)

    Contact: Study coordinator (Onur Güner) · onurguner@ascotscience.com

  • S.B.U. Dr. Behcet uz Pediatric Diseases and Surgery Training and Research Hospital, Izmir, Turkey (Türkiye)

    Contact: Study coordinator (Zeynep Erturk) · zeyneperturk@ascotscience.com
View source on ClinicalTrials.gov(opens in a new tab)